What is the recommended dosage and administration instructions for benzonatate?

Benzonatate Dosing Recommendation

The recommended dosage of benzonatate is 100-200 mg three times daily (every 8 hours) as needed for cough, with a maximum daily dose of 600 mg in three divided doses. 1

Standard Dosing Protocol

Adults and Children Over 10 Years

• Usual dose: 100-200 mg orally three times daily (TID)
• Maximum dose: 600 mg per day in three divided doses
• Onset of action: 15-20 minutes
• Duration of effect: 3-8 hours 1

Critical Administration Instructions

Benzonatate capsules must be swallowed whole - never broken, chewed, dissolved, cut, or crushed 1. This is a critical safety measure because:

• Release of medication in the mouth causes immediate local anesthesia of oral mucosa
• Can lead to choking, numbness of tongue/mouth/throat/face
• If oral numbness occurs, patients must refrain from eating or drinking until sensation returns 1

Special Dosing Considerations

For Refractory Cough (Lung Cancer Context)

In patients with opioid-resistant cough that fails peripheral antitussives, benzonatate is dosed at 100-200 mg four times daily (QID) 2. This represents a more aggressive dosing schedule for palliative care situations.

Timing Considerations

• Avoid food and drink for at least 1 hour after administration when used for certain indications 2
• For first-time use in high-risk patients, consider administering the first dose in a monitored setting due to potential reflex bronchospasm 2

Critical Safety Warnings

Pediatric Restrictions

• Contraindicated in children under 10 years of age - safety and effectiveness not established 1
• Accidental ingestion in young children has resulted in death within 15-60 minutes 1, 3
• Keep strictly out of reach of children - this is a high-risk medication for pediatric poisoning

Overdose Risk

• Signs of toxicity can appear within 15-20 minutes of ingestion 1, 3
• Serious effects include: seizures, cardiac arrest, dysrhythmias, coma, respiratory arrest 4, 3
• Never exceed 200 mg per single dose or 600 mg daily 1
• If a dose is missed, skip it - never double dose 1

Clinical Context and Positioning

Benzonatate functions as a peripherally-acting local anesthetic that dampens stretch receptor activity in respiratory passages 1. In treatment algorithms:

1. It is positioned as a third-line or later agent for refractory cough
2. Used after demulcents and opioid derivatives have failed 2
3. Particularly relevant for opioid-resistant cough in palliative care settings

Important Caveats

• Evidence for benzonatate efficacy is limited and of low quality 5
• The combination with guaifenesin 600 mg may provide enhanced antitussive effects compared to either agent alone 6
• If no improvement occurs after a short trial, discontinue and try alternative approaches 2

Pregnancy and Lactation

• Pregnancy Category C - use only if clearly needed 1
• Unknown if excreted in breast milk - exercise caution in nursing mothers 1